OncoCyte (OCX) has news. This firm, which develops non-invasive blood and urine liquid biopsy diagnostic tests …

Prohost Letter #405 Synthetic Biology (3) We have already decided upon becoming shareholders the day synthetic …

A few days ago, the FDA approved Lexicon Pharmaceutical’s (LXRX) drug Xermelo™ (telotristat ethyl) 250 mg …

We keep reiterating that CAR-T cancer immunotherapy was created to stay. More frequent updates about the …

Incyte Announces a Multi-year Research Collaboration with the Abramson Cancer Center at the University of Pennsylvania. …

Some investors are selling AGEN in premarket trading for a reason that might be unimportant anymore …

About the CRISPR/Cas9 Gene Editing Patent Shareholders of biotechnology firms specialized in CRISPR gene editing technology …

Incyte (INCY) and Agenus (AGEN) announced an amendment of the License, Development and Commercialization Agreement that …

Gilead Sciences (GILD) was subjected to what we believe is an exaggerated stock selloff following the …

XOMA Establishes Proof-of-Concept for 358 in Congenital Hyperinsulinism and Hypoglycemia Post-Bariatric Surgery Congenital Hyperinsulinism Phase 2 …